Drug Profile
Enzaplatovir - Vaxart
Alternative Names: BTA C585; BTA585Latest Information Update: 16 Feb 2018
Price :
$50
*
At a glance
- Originator Biomolecular Research Institute; Biota Holdings
- Developer Aviragen Therapeutics
- Class Antivirals; Imidazoles; Isoxazoles; Pyrazines; Pyridines; Small molecules
- Mechanism of Action Viral fusion protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Respiratory syncytial virus infections